0000000000921695

AUTHOR

Simon M. Ametamey

showing 3 related works from this author

PET Chemistry: An Introduction

2021

One major advantage of radioactivity is its extremely high sensitivity of detection. Regarding the medical applicability of radioactivity, it permits non-invasive in vivo detection of radiolabelled compounds at nano- to picomolar levels. The use of substances at such low concentrations usually precludes a physiological, toxic or immunologic response of the investigated biological system. Consequently, the considered physiological process or system is examined in an unswayed situation. Furthermore, a wide range of substances, even those which are toxic at higher concentrations, become considerable for the development of radiopharmaceuticals and use in nuclear medicine. In contrast to the wid…

Medical diagnosticRadionuclidemedicine.diagnostic_testPet chemistryChemistryPositron emission tomographyRadiation doseRadiochemistrymedicineNuclideSingle-photon emission computed tomographyVolume concentration
researchProduct

PET Chemistry: Radiopharmaceuticals

2021

Although many radiolabelled compounds for PET imaging have been developed so far, only a few have reached the status of a clinically established and routinely used PET radiopharmaceutical. At the early stage of development, a reasonable medical indication is obviously fundamental for a PET radiopharmaceutical to be further considered as clinically relevant. However, besides a favourable in vivo behaviour and appropriate imaging characteristics, certain criteria have to be fulfilled, such as a fast, straightforward and reliable radiosynthesis; an assured stability of the label as well as of the compound itself and a good availability of a suitable precursor. In particular, the ease and relia…

Computer sciencePet chemistryOn demandRadiosynthesisPet imagingBiochemical engineering
researchProduct

On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion

2021

Radiochemical conversion is an important term to be included in the "Consensus nomenclature rules for radiopharmaceutical chemistry". Radiochemical conversion should be used to define reaction efficiency by measuring the transformation of components in a crude reaction mixture at a given time, whereas radiochemical yield is better suited to define the efficiency of an entire reaction process including, for example, separation, isolation, filtration, and formulation. (C) 2020 Elsevier Inc. All rights reserved.

Cancer ResearchRadiochemistryNomenclatureRadiochemical conversionChemistryRadiochemistry610 Medicine & health10181 Clinic for Nuclear MedicineTerminology030218 nuclear medicine & medical imagingNuclear chemistryRadiochemical yield03 medical and health sciences0302 clinical medicineddc:5701313 Molecular Medicine030220 oncology & carcinogenesisYield (chemistry)2741 Radiology Nuclear Medicine and ImagingMolecular Medicine1306 Cancer ResearchRadiology Nuclear Medicine and imagingRadiopharmaceutical sciencesConsensus guidelinesNuclear Medicine and Biology
researchProduct